Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era

HAART时代基于机制的视网膜损伤无创评估

基本信息

  • 批准号:
    7860551
  • 负责人:
  • 金额:
    $ 32.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-01 至 2011-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Patients with HIV-disease have responded well to the highly activated antiretroviral therapy (HAART). However, our research group and others have shown that vision loss continues to occur despite elevated CD4 counts. In this grant we plan to assess and quantify retinal damage to the retinal nerve fiber layer (RNFL) and normal retinal tissue with the help of two non-invasive imaging techniques - scanning laser polarimetry (SLP) and optical coherence tomography (OCT). We will test two different hypotheses that might explain the vision loss - one is cytokine mediated optic neuropathy and the other is microvascular ischemia in the retina. The first specific aim of our study is to quantify RNFL defects by SLP, conventional OCT and high-resolution (HR) OCT in a cross-sectional and longitudinal study. RNFL defects are measured along a circumference around the optic nerve head in a manner analogous to studies in glaucoma research. The second specific aim is to quantify retinal defects throughout the posterior pole by HR-OCT in a cross-sectional and longitudinal study, as well. These retinal defects can occur throughout the retina and will be imaged by 3-D images. The third specific aim is correlate the RNFL and retinal defects detected with both imaging instruments with standard visual field function testing, short-wavelength automated perimetry and other structural and function data. Our research team encompasses a group of highly-qualified individuals with various expertise. Our team includes experts on retinal imaging, an expert in the study of HIV-related ocular complications, an expert in neurobehavioral research, and an expert on high-resolution optical coherence tomography.
描述(申请人提供):艾滋病患者对高度激活的抗逆转录病毒疗法(HAART)反应良好。然而,我们的研究小组和其他研究人员已经表明,尽管CD4计数上升,视力损失仍在继续发生。在这笔赠款中,我们计划借助两种非侵入性成像技术-扫描激光偏振(SLP)和光学相干断层扫描(OCT)-评估和量化视网膜神经纤维层(RNFL)和正常视网膜组织的视网膜损伤。我们将测试两种可能解释视力丧失的不同假说--一种是细胞因子介导的视神经病变,另一种是视网膜微血管缺血。我们研究的第一个具体目标是在横断面和纵向研究中通过SLP、常规OCT和高分辨率(HR)OCT对RNFL缺陷进行量化。RNFL缺陷是沿着视神经头周围的圆周测量的,方法类似于青光眼研究中的研究。第二个具体目标是在横断面和纵向研究中,通过HR-OCT对整个后极部的视网膜缺陷进行量化。这些视网膜缺陷可以发生在整个视网膜上,并将通过3D图像进行成像。第三个具体目标是将两种成像仪器检测到的RNFL和视网膜缺陷与标准视野功能测试、短波自动视野检查和其他结构和功能数据相关联。我们的研究团队由一群具有各种专业知识的高素质人员组成。我们的团队包括视网膜成像专家、艾滋病毒相关眼部并发症研究专家、神经行为研究专家和高分辨率光学相干断层扫描专家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dirk-Uwe G Bartsch其他文献

Dirk-Uwe G Bartsch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dirk-Uwe G Bartsch', 18)}}的其他基金

Animal Structure and Function
动物的结构和功能
  • 批准号:
    10709403
  • 财政年份:
    2023
  • 资助金额:
    $ 32.75万
  • 项目类别:
Animal Structure and Function
动物的结构和功能
  • 批准号:
    10222683
  • 财政年份:
    2012
  • 资助金额:
    $ 32.75万
  • 项目类别:
Animal Structure and Function
动物的结构和功能
  • 批准号:
    10426192
  • 财政年份:
    2012
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    8526461
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    7238554
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    8331552
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    8154961
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    10004614
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    7430352
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:
Mechanistic-Based Non-Invasive Assessment of Retinal Damage in HAART Era
HAART时代基于机制的视网膜损伤无创评估
  • 批准号:
    7120309
  • 财政年份:
    2006
  • 资助金额:
    $ 32.75万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 32.75万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 32.75万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 32.75万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 32.75万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 32.75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 32.75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 32.75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 32.75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 32.75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 32.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了